Health
Immune cells in cerebrospinal fluid could be novel biomarkers to immune-based therapies – News-Medical.Net
Results from a study led by Joan Seoane, Director of Preclinical and Translational Research co-program at VHIO and ICREA Professor, show that immune cells accessing…
Results from a study led by Joan Seoane, Director of Preclinical and Translational Research co-program at VHIO and ICREA Professor, show that immune cells accessing cerebrospinal fluid faithfully recapitulate the characteristics of cells identified in brain metastasis, and could therefore constitute novel biomarkers of response to immune-based therapies.
Immune checkpoint inhibitors including anti-PD1, anti-PD-L1, and anti-CTLA4, have shown significant clinical benefits in patients with progressive…
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business14 hours agoSolid superannuation gains continue to roll in
-
General12 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
